← Back to Search

Other

Gravity vs. Vacuum Drainage Systems for Pleural Effusion (NEWTON Trial)

N/A
Recruiting
Led By Lonny Yarmus, DO
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Histocytological proof of pleural malignancy
Plans for placement of IPC within ten days of enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-ipc placement, 12 weeks post ipc placement or time of pleurodesis
Awards & highlights

NEWTON Trial Summary

This trial is testing whether gravity drainage or suction drainage is better for people with a debilitating complication of end stage cancer.

Who is the study for?
This trial is for adults over 17 with malignant pleural effusion, who've felt better after draining fluid from the chest. They must be able to safely have a catheter inserted and manage its care. Excluded are those with certain conditions like bleeding disorders, recent chest surgeries or trauma, very short life expectancy, or current infections.Check my eligibility
What is being tested?
The study compares two ways of draining fluid buildup in the chest due to cancer: using gravity or vacuum suction through an indwelling tunneled pleural catheter (IPC). It aims to see which method improves quality of life and has better outcomes.See study design
What are the potential side effects?
Potential side effects may include discomfort and chest pain during drainage. The extent of these side effects could vary based on whether gravity or vacuum suction is used.

NEWTON Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My cancer diagnosis was confirmed with a tissue sample.
Select...
I am scheduled to get an IPC placed within 10 days of joining.
Select...
I have fluid buildup in my chest that is cancer-related.
Select...
I am older than 17 years.
Select...
I have recurring fluid buildup in my chest due to cancer that has spread.
Select...
I felt better breathing after fluid was drained from my chest.
Select...
I need a chest drain for fluid buildup due to cancer.

NEWTON Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-ipc placement, 12 weeks post ipc placement or time of pleurodesis
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-ipc placement, 12 weeks post ipc placement or time of pleurodesis for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in chest pain as assessed by Visual Analog Scale (VAS)
Secondary outcome measures
Change in Functional Assessment of Chronic Illness Therapy (FACIT)-Dyspnea survey score
Change in SF 36-Item Health Survey score
Change in mean difference in chest pain as assessed by VAS

NEWTON Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GravityExperimental Treatment1 Intervention
The pleural fluid will be drained using gravity drainage to a bag positioned at bedside. Participants in this arm will undergo Gravity-Based IPC.
Group II: VacuumActive Control1 Intervention
The pleural fluid will be drained by the syringe system with a one-way valve tubing system provided in the kit. Selection of the vacuum pressure will be at the discretion of the proceduralist, as per standard of care. Participants in this arm will undergo Vacuum-Based IPC.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,266 Previous Clinical Trials
14,837,297 Total Patients Enrolled
2 Trials studying Pleural Effusion
255 Patients Enrolled for Pleural Effusion
Rocket Medical plcOTHER
4 Previous Clinical Trials
458 Total Patients Enrolled
4 Trials studying Pleural Effusion
458 Patients Enrolled for Pleural Effusion
Swedish Medical CenterOTHER
53 Previous Clinical Trials
8,094 Total Patients Enrolled

Media Library

Gravity-Based IPC (Other) Clinical Trial Eligibility Overview. Trial Name: NCT03831386 — N/A
Pleural Effusion Research Study Groups: Vacuum, Gravity
Pleural Effusion Clinical Trial 2023: Gravity-Based IPC Highlights & Side Effects. Trial Name: NCT03831386 — N/A
Gravity-Based IPC (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03831386 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many healthcare facilities have implemented this trial?

"Patients for this medical study can be found at a number of sites, such as the Medical University of South carolina in Charleston, Vanderbilt University Medical Center in Nashville and Johns Hopkins Hospital in Baltimore. Additionally, there are 5 other locations available."

Answered by AI

Is it possible to still enroll in this research endeavor?

"After reviewing the information available on clinicaltrials.gov, it is clear that recruitment for this study is still active and ongoing. The trial was initially posted on January 31st 2019 and most recently updated on August 26th 2022."

Answered by AI

How many participants are currently being included in this clinical study?

"To ensure that this research trial is successful, 200 patients fitting the inclusion criteria must be recruited. Those eligible to participate reside in various locations including Medical University of South carolina in Charleston and Vanderbilt University Medical Center in Nashville."

Answered by AI
~67 spots leftby Dec 2026